The detection of clinically important disease-specific biomarkers such as proteins, nucleic acids, antibodies, enzymes, viruses and circulating tumor cells is essential for understanding their role in disease diagnosis and prognosis. Thus, current clinical research aims at developing a biosensor for the ultrasensitive, reliable, and specific detection of these low-abundant biomolecules in bodily fluids including urine, saliva, and blood. Electrochemical biosensors are powerful devices that make it simple, quick, and affordable the detection of disease biomarkers in clinical diagnostics Peptides epitomize an intriguing group of biorecognition elements that can be linked to electrochemical transducers owing to their stability and selectivity concerning a target analyte. Moreover, they are amenable to facile synthesis and modification with designated functional groups, rendering them appropriate for the creation of innovative architectures for electrochemical biosensing systems. In this review, we provided an outline of the most recent developments in material designs, recognition systems, and strategy advancements related to fabricating peptide-based electrochemical biosensors for disease biomarker detection. • This review outlined the fabrication of peptide-based electrochemical biosensors for biomarker detection. • Pointed out the recent developments in material designs, recognition systems, and strategy advancements. • A thorough analysis of the connection between the peptide sequence and recognition specificity has been conducted. • The development of label-free techniques provides high sensitivity and selectivity for analytes.
No takes yet. Share an insight, caveat, or question.
Vinod et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: